Podcast 87: Health Care Affordability and High-Quality Care with Dr. Mark Briesacher
Episode Summary
This week’s guest is Dr. Mark Briesacher, Senior Vice President and Chief Physician Executive for Intermountain Healthcare and President of Intermountain Medical Group. Dr. Briesacher talks about Intermountain’s core values and explains the critical success factors behind becoming a leading integrated health system in the United States. He also discusses the future affordability of health care and reveals Intermountain’s aspirational role to provide high-value care at lower costs. Dr. Briesacher also leads Intermountain’s podcast, and in the interview he addresses how Intermountain uses podcasts as a successful vehicle for employee engagement.About Darwin Research Group Darwin Research Group Inc. provides advanced market intelligence and in-depth customer insights to health care executives, with a strategic focus on health care delivery systems and the global shift toward value-based care. Darwin’s client list includes forward-thinking biopharmaceutical and medical device companies, as well as health care providers, private equity, and venture capital firms. The company was founded in 2010 as Darwin Advisory Partners, LLC and is headquartered in Scottsdale, Ariz. with a satellite office in Princeton, N.J.
Episode Notes
This week’s guest is Dr. Mark Briesacher, Senior Vice President and Chief Physician Executive for Intermountain Healthcare and President of Intermountain Medical Group. Dr. Briesacher talks about Intermountain’s core values and explains the critical success factors behind becoming a leading integrated health system in the United States. He also discusses the future affordability of health care and reveals Intermountain’s aspirational role to provide high-value care at lower costs. Dr. Briesacher also leads Intermountain’s podcast, and in the interview he addresses how Intermountain uses podcasts as a successful vehicle for employee engagement.
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Recommended Next
Darwin's Our Take: Feature: A rare FDA refusal, CDC grant cuts, and proposed ACA exchange changes

Darwin's Our Take: Lilly’s, Novo Nordisk’s share prices roller-coaster following earnings reports

Darwin's Our Take: Botox, Trulicity, Xolair among drugs selected for next round of Medicare price negotiations

Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.







